Deep Vein Thrombosis Leg
8
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
25.0%
2 terminated out of 8 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
ClotTriever Outcomes (CLOUT) Registry
Compression Hosiery to Avoid Post-Thrombotic Syndrome
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation
Use of Bedside Ultrasound in Emergency Department Patients With Concern for Pulmonary Embolism to Reduce CT Imaging
A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting